For decades, global capital markets have operated with a systematic blind spot. Not in technology. Not in energy. In women’s health. Maryann Selfe, a Swiss-based global wealth and investment strategist and two-decade veteran of institutional capital allocation, exposes this failure in her new book “The Billion Dollar Blindspot.” The thesis is startling: The same system that excluded half the population from clinical research created a trillion-dollar arbitrage opportunity. Selfe’s discovery was personal.